| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.36▼ | 0.33▲ | 0.31▲ | 0.26▲ | 0.27▲ |
| MA10 | 0.35▲ | 0.30▲ | 0.28▲ | 0.24▲ | 0.28▲ |
| MA20 | 0.32▲ | 0.27▲ | 0.25▲ | 0.25▲ | 0.34▲ |
| MA50 | 0.29▲ | 0.22▲ | 0.22▲ | 0.29▲ | 0.58▼ |
| MA100 | 0.26▲ | 0.23▲ | 0.24▲ | 0.36▼ | 0.84▼ |
| MA200 | 0.23▲ | 0.26▲ | 0.27▲ | 0.56▼ | 1.88▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.010▲ | 0.013▲ | 0.012▲ | 0.011▲ |
| RSI | 67.576▲ | 78.556▲ | 77.052▲ | 67.001▲ | 45.528▼ |
| STOCH | 88.669▲ | 89.938▲ | 89.591▲ | 53.588 | 24.148 |
| WILL %R | -25.084 | -15.170▲ | -13.033▲ | -10.435▲ | -34.854 |
| CCI | 71.433 | 191.723▲ | 221.657▲ | 230.053▲ | -3.477 |
|
Wednesday, April 08, 2026 08:00 AM
Boston, USA-based Cue Biopharma announced that it will receive a $7.5 million pre-clinical milestone payment under its collaboration and license agreement with Boehringer Ingelheim following the ...
|
|
Wednesday, April 08, 2026 06:03 AM
Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanistic effect of CUE-501 for T ...
|
|
Wednesday, April 08, 2026 05:31 AM
Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanistic effect of CUE-501 for T cell- ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/04/26 | 0.2928 | 0.3794 | 0.2905 | 0.3571 | 6,795,833 |
| 09/04/26 | 0.2493 | 0.295 | 0.21 | 0.2929 | 11,369,882 |
| 08/04/26 | 0.187 | 0.2799 | 0.18 | 0.2738 | 41,153,676 |
| 07/04/26 | 0.209 | 0.2271 | 0.1719 | 0.1882 | 76,746,345 |
| 06/04/26 | 0.178 | 0.1894 | 0.1657 | 0.177 | 1,799,773 |
| 02/04/26 | 0.192 | 0.20 | 0.174 | 0.1799 | 1,445,244 |
| 01/04/26 | 0.2253 | 0.2299 | 0.20 | 0.2026 | 1,387,978 |
| 31/03/26 | 0.22 | 0.2335 | 0.2174 | 0.2299 | 570,932 |
| 30/03/26 | 0.225 | 0.2336 | 0.2127 | 0.226 | 422,043 |
| 27/03/26 | 0.2409 | 0.2417 | 0.2224 | 0.2394 | 1,140,377 |
|
|
||||
|
|
||||
|
|